EnteraSense Limited is a medical device sensor diagnostic company founded in 2015 by Donal Devery, Dr. Marvin Ryou, and Dr. Chris Thompson of Brigham and Women’s Hospital/Harvard Medical School in the United States.
Location: Mervue Galway
The company is based in Galway, Ireland and has a licensed technology agreement from Brigham and Women’s Hospital/Harvard Medical School which enables the company to develop devices for diagnosing and monitoring Upper Gastric Bleeds.
Initial Seed Funding
EnteraSense raises an initial seed funding round of €1m.
Irish medtech startup gets €2.5m grant boost
Courtesy Charlie Taylor - Irish Times Jan 09, 2019 EnteraSense, a Galway-based medical technology start-up has secured €3.5 million in funding through a combination of private seed investment and an EU Horizon
May 2020 EnteraSense Submitted to the FDA.
Manufacturing line has been developed, agreed and tested. Initial product is currently under manufacturing for release in October 2020.
First In Human & Clinical Trials
Protocols & approvals have been obtained from the relevant competent authorities.
FIH - Czech Republic
Successful completion of FIH in Q1 2021
Based in Galway, Ireland we have a licensed technology agreement from Brigham and Women’s Hospital/Harvard Medical School which enables us to develop ground-breaking devices for diagnosing and monitoring Upper Gastric Bleeds.